Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolapitant IV DDI Study with Digoxin, Sulfasalazine, and Cooperstown Cocktail
NCT02434861Phase 1Completed
- Start
- May 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rolapitant in chemotherapy-induced nausea and vomiting (CINV) (3 arms). Primary endpoints: Area Under the Plasma Concentration-Time Curve and Observed Maximum Plasma Concentration. Started May 2015; status: completed.
02
Drugs
rolapitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02434861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434861.